Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells
In order to improve its oral bioavailability, different formulation techniques such as coadministration with piperine, incorporation into micelles, micro/nanoemulsions, nanoparticles, liposomes, solid dispersions, spray drying, and noncovalent complex formation with galactomannosides have been investigated with in vitro cell culture models, in vivo animal models, and humans
You can view the product page here: BPC-157 Research Peptide
VitalBP (sold at myvitalbp.com) is an entirely different product with a different formula, different manufacturer, and different pricing
3.4 Procyanidins Specifically proanthocyanidins, have demonstrated potential in PsO treatment through their antioxidant and anti-inflammatory properties
Medical Advice: This content is for informational purposes only and does not constitute medical advice